CSIMarket
 
Linkwell Corp  (LWLL)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 120
 Employees -
 Revenues (TTM) (Millions $) 10
 Net Income (TTM) (Millions $) 4
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Linkwell Corp
Linkwell Corp is a multinational corporation that specializes in the manufacturing and distribution of various consumer products. The company has a wide range of product categories including personal care products, household items, food and beverages, and pet care products. Linkwell Corp operates in several countries around the world and has established a strong presence in the market through its diverse portfolio of brands. The company focuses on delivering high-quality and affordable products that cater to the needs and preferences of its customers. Additionally, Linkwell Corp is committed to sustainable practices and social responsibility, aiming to minimize its environmental footprint and contribute positively to the communities it operates in.


   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Prosomnus Inc

Prosomnus Inc Announces Revenue Increase to $9.345763 Million for Fiscal Year Ending December 31, 2023

ProSomnus Inc Announces Revenue Increase and Groundbreaking Development
Prosomnus Inc, a leading innovator in the field of sleep medicine, has disclosed a revenue of $9.345763 million for the fiscal span closing December 31, 2023. However, the company reported a net deficit of $-6.869 million for the same reporting season, indicating a decline compared to the previous year's zero gain.
One notable observation is the significant increase in inventories and supplies, reaching $2.0 million. This figure is higher than the preceding quarter and also higher than the corresponding quarter a year ago. This buildup in inventories can suggest positive optimism for future sales and demand for Prosomnus Inc products.
Furthermore, the company saw a notable increase in accounts receivable, which reached a value of $3.8 million compared to the preceding quarter. This rise also signals an increase in demand and is an encouraging sign for investors.

Orchestra Biomed Holdings Inc

Orchestra BioMed Holdings Inc. Achieves Significant Milestone with $0.262 Million Revenue in Q4

Orchestra BioMed Holdings, Inc. is a biomedical company that is dedicated to bringing high-impact technologies to patients through partnerships that share both the risks and rewards. Recently, the company conducted a clinical study to evaluate the efficacy of Atrioventricular Interval Modulation (AVIM) therapy, also known as BackBeat CNT, in pacemaker-indicated patients with uncontrolled hypertension.
The study aimed to compare AVIM therapy with standard right ventricular (RV) pacing in terms of systolic blood pressure and overall cardiac function. The results of this pressure-volume (PV) loop study, conducted at Na Homolce Hospital in Prague under the supervision of Prof. Petr Neuil, M.D., were presented at the Technology and Heart Failure Therapeutics (THT) 2024 Meeting by Prof. Karl-Heinz Kuck, M.D., Medical Director at LANS Cardio Hamburg.

Delcath Systems Inc

Evanescence of Losses at Delcath Systems Inc. Signals Positive Growth in Q4 Fiscal Period 2023

Delcath Systems, Inc., a renowned interventional oncology company focusing on the treatment of primary and metastatic liver cancers, recently announced Martha S. Rook as its new Chief Operating Officer (COO). This strategic appointment is expected to enhance Delcath's operations and drive further advancements in innovative liver cancer treatments.
Martha S. Rook brings a wealth of experience to Delcath Systems, with a strong background in the healthcare and pharmaceutical industries. With her impressive track record in leadership positions, including her most recent role as Vice President of Operations at a prominent oncology therapeutics company, Rook is well-equipped to improve operational efficiency, streamline processes, and foster business growth at Delcath.

Qt Imaging Holdings Inc

QT Imaging Holdings Inc. Appoints New Leadership Team to Drive Growth and Innovation in Medical Device Industry

QT Imaging Holdings Inc. (NASDAQ: QTI) has recently undergone a significant leadership change with the appointment of Dr. Raluca Dinu as the Acting Chief Executive Officer and Anastas Budagov as the Chief Financial Officer. This move is aimed at strengthening the company's position in the medical device industry, particularly in the research, development, and commercialization of body imaging systems.
Dr. Dinu brings a wealth of experience to her new role, having previously served as the CEO of GigCapital5, Inc. Her proven track record in driving innovation and growth makes her an excellent choice to lead QT Imaging Holdings during this critical phase. Her appointment, effective from March 12, 2024, is expected to enrich the company's strategic decision-making process as she joins the Board of Directors.

Innovative Eyewear Inc

Innovative Eyewear Inc Fails to Turn Profit despite Surge in Revenue during Fourth Quarter of 2023

Innovative Eyewear Inc, a Medical Equipment and Supplies company, recently announced a significant increase in revenue for the most recent fiscal period. Despite this positive growth, the company reported a loss of $0.28 million. However, this improvement in revenue in the fourth quarter of 2023 aligns with other companies in the Medical Equipment and Supplies industry, which collectively experienced a 6.74% increase in revenue during the same period.
Compared to the previous reporting period, Innovative Eyewear Inc saw an advanced shortfall from $-0.12 per share and a doubling of revenue by 177.523%, amounting to $0.22 million. In the fourth quarter of 2023, the company reported a net shortfall of $-2.394 million, a significant improvement from the $-4.278 million deficit in the same period a year ago.






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com